BioSig Technologies, Inc. announced the appointment of Mr. Anthony Amato to the Position of Chief Executive Officer (?CEO?), effective immediately.  Additionally, Mr. Amato will serve on the Company?s Board of Directors, which is currently being assembled.  Personal Bio, Mr. Anthony Amato - Age 56: Anthony Amato is a business leader and entrepreneurial thinker with an intuitive ability to rapidly assess challenges and identify growth opportunities. He quickly sees organizational vision and understands goals, taking appropriate ownership and action required to guide the team, achieving aggressive targets and performance levels. He has outstanding interpersonal, business development, team building and management skills.

Anthony has hands-on executive skills at engaging and influencing key stakeholders to not only grow business but also to optimize profits. Mr. Amato founded InQuest Science in March 2017 and then acquired Bridge Associates International Pharmaceutical Consulting in March 2020. He is the former Director of Sales for Mesa Labs in Denver CO, a Nasdaq listed corporation that specializes in providing quality control products and services to ensure the safety and efficacy of equipment used in hospitals, pharmaceutical, medical device manufacturers, blood banks, laboratories, pharmacies, and industrial facilities.

In July of 1999, he founded Amega Scientific Corporation. He grew the company from a start-up operation to a worldwide industry leader. Anthony developed and managed a staff throughout North America, establishing R&D, production, logistics, administration and sales.

Clients included pharmaceutical, biotech, hospitals, government facilities, and research universities. Amega Scientific was the leading innovator in the Environmental Monitoring System industry. Amega Scientific was an ISO 17025 corporation instituting GxP requirements.

Amega Scientific was acquired by Mesa Labs (MLAB) in November 2013. Mr. Amato graduated from Glassboro State College in New Jersey in 1989, with a dual degree in business management and finance.